Marina N Sharifi
Marina N Sharifi
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer | HER2-negative Breast Cancer; Hormone Receptor Positive Breast Carcinoma; PIK3CA Mutant Metastatic Breast Cancer | Active, not recruiting | Phase 2 | 2026-01-02 | NCT04762979 |